E2F1 and neoplasm: We report here that E2F1 physically interacts with active STAT3 and synergistically controls IL-6 expression to induce a tumor-associated inflammatory GRN that ultimately mediates metastatic traits and modulates the TME by releasing immunomodulatory factors.